Aortic & mitral valves galore plus bioresorbable scaffold results: T3 Labs’ insights from TCT 2016
The Cardiovascular Research Foundation’s annual TCT conference serves as the premier cardiovascular event of the year: delivering the latest clinical and preclinical updates on a wide spectrum of transcatheter therapies and the 2016 edition was no exception. In addition to catching up with existing and prospective sponsors and FDA regulators, here are a few of…